Immunity and protection of SARS-CoV-2DNA and protein vaccines

A DNA vaccine against SARS-CoV-2 virus infection in a subject is provided, which comprises a codon optimized polynucleotide sequence encoding a polypeptide of the SARS-CoV-2 virus. The invention also provides a vaccine combination for resisting SARS-CoV-2 virus infection, and the vaccine combination...

Full description

Saved in:
Bibliographic Details
Main Authors LIU XIAOJUAN, LI ZHIHUA, XIAO HONGJIAN, BI YANWEI, LI YUZHONG, LU SHAN, LI QIHAN, CUN WEI
Format Patent
LanguageChinese
English
Published 22.08.2023
Subjects
Online AccessGet full text

Cover

More Information
Summary:A DNA vaccine against SARS-CoV-2 virus infection in a subject is provided, which comprises a codon optimized polynucleotide sequence encoding a polypeptide of the SARS-CoV-2 virus. The invention also provides a vaccine combination for resisting SARS-CoV-2 virus infection, and the vaccine combination comprises the DNA vaccine and an antigen peptide vaccine. In the NHP research, the vaccine composition can endow comprehensive protection against SARS-CoV-2 virus infection. 提供了在受试者中抗SARS-CoV-2病毒感染的DNA疫苗,其包含编码SARS-CoV-2病毒的多肽的经密码子优化的多核苷酸序列。还提供了抗SARS-CoV-2病毒感染的疫苗组合,其包含所述DNA疫苗和抗原肽疫苗。在NHP研究中,该疫苗组合能够赋予抗SARS-CoV-2病毒感染的全面保护。
Bibliography:Application Number: CN202180078930